Şunu aradınız:: secţiunea 4 perspectivele comerciale (Romence - İngilizce)

secţiunea 4
section 4

secţiunea 4.
box 4.

vezi secţiunea 4.
see section 4

sub-secţiunea 4
subsection 4

secŢiunea 4 sancŢiuni
section 4 sanctions

vezi secţiunea 4. 7.
see also section 4.7.

secţiunea 4 titlul d
section 4title d

(vezi secţiunea 4. 10).
if the animal licks the application site after treatment, transient neurological signs may be observed infrequently (see section 4.10 –).

secŢiunea 4 dispoziŢii comune
section 4 common provisions

secţiunea 4. 1 (indicaţie):
section 4.2 (posology): “ paediatric patients gadograf is not recommended for use in population below age 18 due to a lack of data on efficacy and safety.

(vezi şi secţiunea 4. 10).
if the animal licks the application site after treatment, transient neurological signs may be observed infrequently (see section 4.10 –).

86 secţiunea 4 plata cheltuielilor ........................................................................................
(4) for the purposes of establishing and implementing the budget, the four fundamental principles of budgetary law (unity, universality, specification, annuality), and the principles of equilibrium, unit of account, sound financial management and transparency must be reasserted.

vezi secţiunea 4. 5 şi 6. 6.
see sections 4.5. and 6.6

secţiunea 4 evidenţa şi raportarea rezultatelor
section 4 recording and reporting of results

indicaţii terapeutice (rcp secţiunea 4. 1)
therapeutic indications (spc section 4.1)

rezumatul caracteristicilor produsului secţiunea 4. 3 contraindicaţii
- when cimetidine (weak inhibitor of cyp1a2, cyp2d6 and cyp3a4) is administered with

secŢiunea 4 productivităţi reprezentative şi cantităţi de livrat
section 4 representative yields and quantities delivered

secţiunea 4: conţinutul prospectului în cazuri speciale..................................
without prejudice to any other action or penalties which they may contemplate in the event of failure on the part of the issuer to comply with the obligations resulting from admission to official listing, the competent authorities may make public the fact that an issuer is failing to comply with those obligations.

rezumatul caracteristicilor produsului secţiunea 4. 1 indicaţii terapeutice
international normalized ratio (inr) in subjects treated with warfarin.

secŢiunea 4 dispoziţii speciale privind anumite poziţii de bilanţ
section 4 special provisions relating to certain balance-sheet items